 |
 |
| Need direction on your next international move? Look no further. |
| For pharmaceutical executives who wish to expand into new global markets, an insider’s perspective is invaluable. Get the insights you need to make your next move a success with exclusive analysis from Pharma Reports. |
| Learn more about the developments and challenges in countries with expanding pharmaceutical markets through interviews and articles from key industry stakeholders. |
| Why choose just 1? Save up to 15% when you buy 4 or more reports. |
 |
| Canada: Canadian health innovation has lagged behind the United States and Europe, but is currently establishing a global reputation for clinical trials, biotech, genomics, medical cannabis, and other areas. |
|
|
|
| Brazil: As the worlds’ sixth largest pharma market, Brazil is becoming increasingly important in the strategies of healthcare companies. How will the market continue to evolve as it exits a two-year recession period? |
|
|
|
| Baltics: While Lithuania, Latvia, and Estonia have much in common, the Baltic states are not a homogenous block. Examine the peculiarities of these small but promising markets, as well as the ways they are working together to propel the industry forward. |
|
|
|
| Poland: Poland possesses a solid foundation for success in the healthcare and life sciences sector. Learn more about the factors at play in this rapidly evolving landscape, to include the biosimilar niche, parallel trade, and therapeutic areas such as cardiology and women’s health. |
|
|
 |
IndustryMatter is your exclusive online resource for clinical, educational, marketing and management products from the award-winning publications and events of UBM Americas and partners.
To learn more, go to industrymatter.com. |
|
